ADVERTISEMENT
ADVERTISEMENT
Indian-origin oncologist receives WashU Dean's Medal
Award recognizes Dr. Ramaswamy Govindan's contributions to lung cancer research and patient care.
-
Ankita Baidya - Fri, 26, Jun 2026
- 04:54 EDT
- 35
Dr. Ramaswamy Govindan receives the 2026 WashU Medicine Dean's Medal for Clinical Excellence. / WashU
Indian-origin medical oncologist Dr. Ramaswamy Govindan has been awarded the 2026 Dean's Medal for Clinical Excellence by WashU Medicine, recognizing his longstanding contributions to lung cancer research, patient care, and academic medicine.
According to a June 25 announcement by the institution, Govindan is among six recipients of this year's Dean's Medals, which honor exceptional contributions across WashU Medicine's missions of clinical care, education, research, leadership, and innovation.
Also Read: Indian-American physician Sunita Reddy publishes debut novel
Govindan earned his medical degree from the University of Madras in India before completing a residency at the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) in Puducherry. He later trained in internal medicine at Michael Reese Hospital in Chicago and completed a fellowship in hematology and oncology at Washington University in St. Louis. He joined the university's faculty in 1998.
A nationally and internationally recognized specialist in thoracic malignancies, Govindan treats patients with lung cancer, pleural mesothelioma, and esophageal cancer at the Alvin J. Siteman Cancer Center, where he translates research advances into clinical care. He serves as the Anheuser-Busch Endowed Chair in Medical Oncology, Associate Chief of the Division of Oncology, and Associate Director of Translational Research at the cancer center.
His research has focused on advancing precision medicine for lung cancer. Govindan is co-chair of the lung cancer group for The Cancer Genome Atlas, a national project studying the genomic changes that drive cancer, and leads the ALCHEMIST trial, a nationwide Phase III clinical study evaluating targeted therapies for patients with early-stage lung cancer based on the molecular characteristics of their tumors.
WashU Medicine said the Dean's Medal for Clinical Excellence recognizes Govindan's decades of leadership in improving cancer care while advancing research that has influenced the treatment of thoracic cancers.
The other 2026 Dean's Medal recipients are Carol Loeb for leadership and service, Dr. Dominique Cosco for education, Dr. Jeffrey I. Gordon for research, and Drs. Randall Bateman and David Holtzman, who shared the award for innovation and commercialization. Bateman and Holtzman co-founded C2N Diagnostics, a WashU startup developing blood-based tests for the early detection of Alzheimer's disease, while Gordon was recognized for pioneering research on the human gut microbiome.
The Dean's Medals were established in 2025 by Dr. David Perlmutter, executive vice chancellor for medical affairs and dean of WashU Medicine, to recognize individuals whose work has made a lasting impact on medicine and healthcare.
Discover more at New India Abroad.
Related
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login